Introduction
Cigarette smoking contributes to millions of preventable deaths each year (http://www.wpro.who.int/media_centre/ fact_sheets/fs_20060530.htm) and is the most important cause of lung cancer, cancer-related death, and chronic obstructive lung disease (Parkin et al. 2005) . Despite the strong correlation between smoking and disease, only a modest fraction (10-15 %) of smokers develop lung cancer (Shields 1999) . Recent studies have demonstrated that cigarette exposure damages epithelial cells in the bronchial airway, creating a molecular field of injury that may represent an early stage of carcinogenesis (Franklin et al. 1997; Slaughter et al. 1953; Spira et al. 2004; Steiling et al. 2008) . Gene expression profiling of cytologically normal bronchial epithelial cell brushings obtained from nonsmokers, healthy smokers and smokers with and without lung cancer, has revealed a number of differentially expressed genes and gene pathways among these groups (Spira et al. 2004 (Spira et al. , 2007 . Prominent features of the injured bronchial cells include altered gene expression for oxidative stress, xenobiotic and DNA damage response genes (Spira et al. Abstract Chronic cigarette smoking exposes airway epithelial cells to thousands of carcinogens, oxidants and DNAdamaging agents, creating a field of molecular injury in the airway and altering gene expression. Studies of cytologically normal bronchial epithelial cells from smokers have identified transcription-based biomarkers that may prove useful in early diagnosis of lung cancer, including a number of p53-regulated genes. The ability of p53 to regulate transcription is critical for tumor suppression, and this suggests that single-nucleotide polymorphisms (SNPs) in functional p53 binding sites (p53 response elements, or p53REs) that affect gene expression could influence susceptibility to cancer. To connect p53RE SNP genotype with gene expression and cancer risk, we identified a set of 204 SNPs in putative p53REs, and performed cis expression quantitative trait loci (eQTL) analysis, assessing associations between SNP genotypes and mRNA levels of adjacent genes in bronchial epithelial cells obtained from 44 cigarette smokers. To further test and validate these genotype-expression associations, we searched published eQTL studies from independent populations and 1 3 2004), presumably due to the presence of oxidants and DNA-damaging agents in cigarette smoke. Variability in the airway's transcriptome response to damage from tobacco smoke among smokers appears to be associated with risk of lung cancer, and these airway gene expression profiles may potentially serve as an early diagnostic biomarker for disease (Spira et al. 2007; Steiling et al. 2008) .
The observations that individuals differ in the response to smoking suggest a possible role for genetic variability in susceptibility to development of lung cancer. Genome-wide association studies have identified many single-nucleotide polymorphisms (SNPs) associated with lung cancer risk but the mechanisms linking SNP genotype to biological function are largely unknown. We and others (Dunham et al. 2012; Schadt et al. 2008; Tomso et al. 2005 ) have hypothesized that these SNPs impact the regulation of cancer genes by affecting transcription factor binding. A number of studies have examined the relationship between SNPs and in vitro gene expression in cell lines (Cheung et al. 2005; Morley et al. 2004; Stranger et al. 2005 Stranger et al. , 2007 Wang et al. 2007 ) to identify expression quantitative trait loci (eQTLs). Using a bioinformatics-directed approach related to the present work, Wang et al. (2007) examined SNPs occurring in binding sites of the transcription factor NRF2 (NFE2L2), predicted the functional impact, and compared genotype with in vitro expression of HapMap lymphoblastoid cell lines. Until recently, there were relatively few eQTL studies comparing genotype with in vivo expression in primary human tissues (Schadt et al. 2008; Wang et al. 2010 ) but now it is possible to compare candidate eQTLs across numerous studies.
The p53 pathway is central in the response to DNA damage, and p53 is frequently mutated in lung cancer. The p53 protein is activated following DNA damage and binds response elements (REs) found in the regulatory regions of p53 target genes. Depending on the exposure and the extent of damage, the subsequent transactivation or repression of target genes results in divergent outcomes including cell cycle arrest or apoptosis (Riley et al. 2008) . We hypothesized that cigarette smoke-induced gene transcription in the airway may be modulated by genetic variation, SNPs in p53 binding sites, which affect p53 binding and may be associated with cancer susceptibility. To test this hypothesis, we carried out a pilot study using the approach shown in Fig. 1 , identifying p53RE SNPs, and assessing the association of SNP genotypes with gene expression profiles in a discovery set of samples from cytologically normal airway epithelial cells obtained at bronchoscopy from smokers. SNPs were evaluated for functional effects on p53 binding to DNA using an in vitro microsphere-based protein binding assay. We then asked if SNPs' effect on expression identified in this study was reproducible in independent genome-wide eQTL studies or if these SNPs were associated with cancer risk, either in GWAS or candidate gene studies. Our findings suggest this is a useful approach for identifying and evaluating potentially functional SNPs that may modulate the airway gene expression response to smoking and might influence risk for developing tobacco-related lung cancer.
Materials and methods

Study population and airway epithelial cell collection
Previously, we recruited a group of current and former smokers who were undergoing bronchoscopy as a diagnostic study for clinical suspicion of lung cancer at four institutions: Boston University Medical Center, Boston Veterans Administration, Lahey Clinic and St. James's Hospital (Spira et al. 2007 ). The study was approved by the Institutional Review Boards of all medical centers, and all participants provided written informed consent. These subjects were included in a previous study of gene expression (Spira et al. 2007; Wang et al. 2010) and 45 % of the smokers were later diagnosed with lung cancer. As described in Wang et al. (2010) considerably among the patients in this study and we identified 12 probe-sets (representing 11 genes) with expression strongly correlated with age at FDR 0.1 level; these probes were excluded from further analysis. For this study normal bronchial airway epithelial cells were obtained from the uninvolved mainstem bronchus with an endoscopic cytobrush (Cellebrity Endoscopic Cytobrush, Boston Scientific). RNA was extracted, and its integrity and epithelial cell content were confirmed as described previously (Spira et al. 2007 ).
Microarray gene expression data acquisition and preprocessing
Approximately, eight micrograms of total RNA was processed, labeled and hybridized to Affymetrix HG-U133A GeneChips containing 22,283 probe-sets as described previously (Spira et al. 2007 ). The MAS 5.0 algorithm was used for background adjustment, normalization, and probelevel summarization of microarray data. All microarray data have been submitted to the Gene Expression Omnibus (GEO) under accession number GSE19027.
Selection of putative p53 response element SNPs
Putative p53 response element SNPs were selected using a published approach developed by our group (Bandele et al. 2011; Tomso et al. 2005; Wang et al. 2007 ). Briefly, we constructed a position weight matrix (PWM) for the p53 binding sites based on the collection of experimentally validated binding sites. Then, we predicted p53REs among all SNP sequences in dbSNP (build 126) using the PWM and mapped putative p53RE SNPs to genes within a 100 kb window of the transcription start site (TSS) and the transcription end site (TES). We selected 307 of these putative p53RE SNPs for genotyping.
SNP genotyping
Utilizing Illumina's Assay Design Tool, we designed Illumina GoldenGate assays for a total of 307 putative functional p53RE SNPs. DNA samples derived from whole blood were genotyped according to the manufacturer's protocol using the Illumina BeadStation 500G GoldenGate genotyping platform. Genotypes were assigned using Beadstudio v3.0 genotyping software with GenTrain scores greater than 0.25. Among successfully genotyped SNPs, 204 had minor allele frequency >0.05 and met the Hardy-Weinberg equilibrium test p > 0.001 (are listed in Supplemental Table 1 ).
Association analysis and permutation testing
A linear regression model was used to evaluate the association between log 2 -transformed expression values of a probe-set and genotypes of a SNP that was within 100 kb from a gene start or end, as previously described (Cheung et al. 2005; Stranger et al. 2005) . To assess the significance of associations, we performed 10,000 permutations of expression values relative to the genotypes. Permutation procedures provide a computationally intensive approach to generate significance levels empirically, and have been used for studies with small sample sizes (Cheung et al. 2005; Morley et al. 2004; Stranger et al. 2005 Stranger et al. , 2007 Wang et al. 2010) . To perform permutation [described in reference (Stranger et al. 2005) ], subject labels were swapped randomly (assuming that individuals are interchangeable under the null) to provide new datasets to be sampled under the null hypothesis. An association was considered nominally significant if the p value from the analysis of the observed data was lower than the threshold of the 0.05 tail of the distribution of the minimal p values from 10,000 permutations. All association tests and permutations were performed using the PLINK software v1.0.3 whole genome association analysis toolset (Purcell et al. 2007 ), available at http://pngu.mgh.harvard.edu/purcell/plink/. We consider the eQTLs identified from these tests as "nominally" significant, and these candidates (Table 1) were then assessed by cross-validation in independent eQTL studies listed in Supplemental Table S4 .
Cross-validation of eQTLs in public eQTL datasets
For each SNP-gene pair identified in this study, we examined if it was also significant in five published eQTL studies (Supplementary Table S4 ) (Grundberg et al. 2012; Liang et al. 2013; Veyrieras et al. 2008; Westra et al. 2013; Zeller et al. 2010) , which have listed cis SNP-gene associations in lymphoblastoid cells, peripheral blood cells, adipose, and skin obtained from ~800 to 5,000 healthy Caucasians. We limited our search to their most significant eQTLs (at FDR 0.05) that reside within the whole coding region plus 100 kb upstream the transcriptional start site (TSS) and 100 kb downstream from the transcriptional end site (TES).
Linking eQTL SNPs with cancer risk
To determine whether our candidate eQTL SNPs were among previously reported cancer-associated SNPs, we first curated cancer-associated SNPs listed in the Catalog of Published genome-wide association studies (GWAS catalog, http://www.genome.gov/gwastudies) and the cancer genome-wide association and meta analyses database (Cancer GAMAdb, http://www.hugenavigator. net/CancerGEMKB) (Yu et al. 2008) ; then, using the linkage disequilibrium (LD) data from the 1000 Genomes Project (Abecasis et al. 2012) , we also identified all SNPs (proxies) that were in strong LD (r 2 ≥ 0.8) with cancer SNPs; last we matched our candidate SNPs with cancerassociated SNPs and their proxies.
Microsphere assay for protein-DNA binding (MAPD)
To characterize the impact of selected SNPs on p53 binding, we utilized a fluorescent microsphere binding assay to evaluate allele-specific p53-DNA interactions (Bandele et al. 2011; Noureddine et al. 2009 ). This microsphere-based flow cytometric assay utilizes fluorescent-dyed beads. Each bead type has a distinct spectral signature and is coated with oligonucleotide sequences containing the p53RE sequences to be tested (Supplementary Table S3 ). The DNA-coated microspheres were hybridized in triplicate with nuclear extracts containing activated p53, and repeated three times. The p53-DNA binding of each allele was quantified using the BioRad Bioplex flow cytometer equipped with a dual laser. It detects both the bead identity and a fluorescent reporter dye attached to the antibody against the target of interest (p53) that is bound to p53RE oligonucleotide coated to the bead. The fluorescence signal intensity reflects relative strength of the p53-DNA interactions. Error bars represent the standard deviation, and significance was assessed by t test.
Results
Association of p53RE SNP genotypes with gene expression in bronchial epithelial cells from cigarette smokers
Our focus in this project was to examine if genotypes of a set of polymorphisms in bioinformatically identified p53 binding sites were associated with mRNA levels in a discovery set of bronchial epithelial cell samples collected by bronchoscopy from smokers with suspicion of cancer (Spira et al. 2007 ). We then aimed to validate any tentatively positive associations in a p53 binding assay and also by comparison with independent eQTL studies ( Fig. 1) . Using a position weight matrix-based bioinformatics approach to identify polymorphic p53 response elements (Bandele et al. 2011) , we selected 307 SNPs in known or putative p53 response elements but only 204 p53RE SNPs had minor allele frequencies large enough (≥0.05) to examine among subjects in this pilot study (Supplemental Table  S1 ). Normalized log 2 -transformed gene expression values were evaluated against SNP genotypes by linear regression in all smokers (n = 44), and permutation-based resampling test was applied as previously described by Stranger et al. (Stranger et al. 2005) . We observed 74 associations (p mperm < 0.05) between SNP genotypes of 60 p53RE SNPs and mRNA levels of 58 nearby genes (68 probe-sets), listed in Supplemental Table S2 .
Because the small number of samples limited statistical power of our test, we further assessed whether the associations observed here could be validated by replication in independent genome-wide eQTL studies. To do this, we queried five eQTL datasets (Grundberg et al. 2012; Liang et al. 2013; Veyrieras et al. 2008; Westra et al. 2013; Zeller et al. 2010) (Supplementary Table S4 ) that report the top 5 % (by FDR) cis SNP-gene associations in lymphoid cell lines (LCLs), peripheral blood cells, monocytes, as well as adipose, and skin tissue that were each obtained from populations ranging from 400 to 5,000 healthy Caucasians. We found that 39 of 74 (53 %) SNP-gene pairs that were nominally significant in our airway epithelial cell study were replicated in at least one of the queried tissues or cells, 14 (19 %) SNP-gene pairs were identified as significant eQTLs across 3 or more studies and remarkably, one association (rs10797056, in the upstream of S100A13) was significant in all queried tissues (Table 1) . To test if our bioinformatics selection of p53RE SNPs was enriching for reproducible eQTLs, we compared the reproducible rate from our study (53 %, 39 of 74) to that among all eQTL studies (14 %, 152,048 of 1,082,839 reported in up to 6500 European ancestry individuals). We found a 6.82-fold enrichment (p = 5.16 × 10 −15 by Fisher's exact test).
Differential binding of p53 to p53RE SNPs associated with gene expression
We selected 25 putative polymorphic p53REs for testing in an in vitro p53 binding assay (Noureddine et al. 2009 ) to evaluate the impact of the SNP on p53 binding (Table 2) . Oligonucleotides containing the p53RE sequence (Supplementary Table S3 ) were attached to fluorescent microspheres, incubated with human cell nuclear extracts containing activated p53 and a fluorescent p53 antibody and the complexes were read on a flow cytometer (Bandele et al. 2011; Noureddine et al. 2009 ). This approach allows the multiplex assessment of relative p53 binding, and the results of three independent trials (in triplicate) are shown in Fig. 2a . Two types of information are displayed by the bars, the relative magnitude of p53 binding to the putative p53 target sequence, and the differential impact that the SNP has on p53 binding. Of these putative p53REs, three (rs3737717, rs347519, and rs2286748) showed strong binding to activated p53, with an additional eight showing moderate binding (rs1704743, rs28371212, rs2290847, rs1042546, rs8006147, and rs292512). The rest showed weak binding (e.g., less than 10 % of p21 element). Several SNP alleles resulted in significant differential binding, including rs7240884, which produced 84 % reduction in binding. The putative p53RE SNP rs347519 resulted in a 51 % reduced binding. Overall, with this small sample of putative p53REs, we found that differential binding was correlated to the difference of PWM scores between predicted strong and weak alleles (r 2 = 0.362, p = 0.0015, Fig. 2b ), suggesting PWM score is a relatively good predictor of p53 binding, consistent with a previous study (Bandele et al. 2011) . We also examined whether or not the differential binding was consistent with the difference of gene expression between predicted strong and weak alleles. Among the eQTL SNPs tested in the binding assay, 92 % (12/13) displayed a directional change in gene expression consistent with PWM score, and for each of the six reproducible eQTL SNPs, we found that the stronger binding allele corresponded to the higher mRNA level. These analyses provide evidence that SNPs affecting p53 binding also have the potential to influence gene transcription.
SNPs associated with gene expression were also associated with cancer susceptibility Given the recent increase in our knowledge of genetic variation important in human cancer through genomewide association studies (GWAS) and candidate gene studies, we sought to determine whether the discovered p53RE eQTL SNPs were among previously reported cancer-associated SNPs. Thus, we looked at the overlap with cancer-associated SNPs listed in the catalog of Published genome-wide association studies [GWAS catalog, http://www.genome.gov/gwastudies, Hindorff et al. (2009)] and the cancer genome-wide association and meta analyses database [Cancer GAMAdb, http://www.hugenavigator. net/CancerGEMKB (Yu et al. 2008) ], including 977 SNPs from GWAS and 309 SNPs from candidate gene studies as of 11/26/2013. We found a p53RE SNP (rs11062386, an eQTL of FKBP4) associated with lung cancer risk, and another p53RE SNP (rs10993994, an eQTL of MSMB) associated with prostate cancer risk.
Because commercial genotyping arrays used in GWAS contain a sample of <10 % of the common SNPs in the genome, most SNPs tested in this study were not directly analyzed in any population study of cancer risk. To identify indirect associations, we used linkage disequilibrium (LD) data from the 1000 Genomes Project (Abecasis et al. 2012) , to determine if any of our SNPs were in strong LD (r 2 ≥ 0.8) with cancer risk SNPs. We further found 5 p53RE SNPs that were in strong LD with 8 cancer risk SNPs (Table 3) . Of note, rs10993994, a putative p53RE SNP associated with prostate cancer risk, was also in strong LD with other 4 SNPs associated with prostate cancer risk. To test if our eQTL SNPs were more likely to be cancer risk SNPs than non-eQTL SNPs, we tested the proportion of each and found that 10.0 % (6/60) of eQTL SNPs were also cancer risk SNPs whereas only 1.6 % (4/247) of noneQTL SNPs were cancer risk SNPs. There was a significant difference in the ratio of cancer risk SNPs between these two groups (enrichment of 6.7-fold, p = 0.0049, by Fisher's exact test). More detailed functional analysis, as well as population studies, will be needed to establish if these connections between putatively functional p53 pathway SNPs and cancer risk are useful in predictive models.
Discussion
This analysis, while limited in scope and statistical power, highlights an approach for linking genetic variants in p53 or other transcription factor binding sites with cancer risk through the regulation of gene expression. A central role for p53 in lung tumors is well established (Herbst et al. 2008; Toyooka et al. 2003) , but there have been relatively few in vivo studies of p53 and p53-regulated gene expression in normal human tissues chronically exposed to cigarette smoke (Lampe et al. 2004) . Early involvement of p53 in lung tumorigenesis has been strongly suggested by studies that have detected mutant p53 DNA sequences in normal tissues and in tissues at the margins of tumors (Ahrendt et al. 1999; Franklin et al. 1997; Harden et al. 2004) . The implication of such events could be altered regulation of p53 pathway genes and susceptibility to transformation. A previous, related study (Spira et al. 2007 ) indicated that gene expression signatures in cytologically normal largeairway epithelial cells can serve as a useful biomarker for early diagnosis of lung cancer, and these signatures may be due to an acquired airway-wide response to cigarette exposure, sometimes termed a "field effect" (Steiling et al. 2008) . We initiated this study with an a priori hypothesis that the p53-mediated airway response to cigarette smoke might be modulated by genetic variation in the p53 pathway, in particular SNPs within p53 binding motifs. Recent reports (Nikulenkov et al. 2012; Zeron-Medina et al. 2013) suggest there may be thousands of possible p53 binding sites (p53REs) in human genome, and in this work we explored an approach that combines bioinformatics, genetics, and population studies for identifying functional polymorphic p53REs.
Using a position weight matrix model to identify potential p53RE SNPs (Bandele et al. 2011) , we scanned dbSNP build 126 and picked 204 p53RE SNPs (MAF ≥0.05) to evaluate as eQTLs in bronchial epithelial cells. The procedure yielded 60 cis-acting, putative p53RE eQTL SNPs associated with 58 genes. We tested a set of 25 p53RE SNPs to determine if they disrupted binding of p53 to DNA and found that 11 elements bound p53 to a substantial degree and 9 displayed significant differential binding. Notably, this functional assay provides evidence that SNPs This pilot study had the goal of testing a bioinformaticsbased method for picking candidate eQTLs in the p53 pathway using bronchial epithelial cells sampled from a small group of individuals being examined for risk of lung cancer. Because the detected bronchial epithelial cell eQTL associations in these groups have limited statistical power, these findings as they pertain to lung cells or lung cancer, need to be verified in larger studies. Thus, while similar studies of lung tissue were unavailable for comparison, we endeavored to validate our findings by querying several independent eQTL databases (Grundberg et al. 2012; Liang et al. 2013; Veyrieras et al. 2008) and found that 39 SNP-gene pairs identified here (53 %) were also observed in at least one of the queried tissues, and 14 were significant in 3 or more queried tissues. This is a highly significant enrichment over the reproducible rate among all eQTL databases (14 %).
Conceptually, it seems that an observation of consistency among SNP functional effects should strengthen biological plausibility of the finding. For example, a SNP that affected p53 binding could reduce transcription of a target gene, resulting in lower expression in tissues of cancer cases, and this might also be reflected in a higher genotype frequency among cancer cases. One disappointing outcome of the present study was that among the bioinformatically chosen p53RE SNPs examined, we were unable to observe consistency across all of the outcomes evaluated. Strategy for selection of SNPs could be improved using p53 chromatin immunoprecipitation sequencing (ChIP-Seq) as a functional screen to identify p53 binding sites and then searching for SNPs within these p53 occupied genomic locations (Zeron-Medina et al. 2013) .
Despite these limitations, it is clear that SNPs that impact p53 binding and p53-induced gene expression could potentially affect cancer risk, thus we searched publicly available SNP databases on cancer risk to determine if any of the SNPs studied had been reported as cancer risk SNPs or if they were in linkage disequilibrium with cancer risk SNPs. We identified that 6 p53 pathway SNPs were associated with both gene expression in bronchial epithelial cells of smokers and risk to various cancers, including one SNP associated with lung cancer risk. It strongly suggests that this pathway-directed, eQTL approach has promise for identifying disease-associated SNPs. Our analysis reveals the potential for genetic modulation of the p53-mediated exposure response pathway in bronchial epithelial cells, and future work will examine this possibility in larger studies. 
